Clinical Trials Directory

Trials / Completed

CompletedNCT00653809

Racial Differences: Nitric Oxide(NO) and Endothelin-1(ET-1) in Preeclampsia (PreE)

Elucidating the Role of Nitric Oxide and Endothelin-1 Activation in Endothelial Cells Co-cultured With Placental Explants From African-american and Caucasian High Risk Pregnancies

Status
Completed
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
University of Mississippi Medical Center · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to examine the activation of markers of endothelial and cardiovascular dysfunctions, from women with high-risk pregnancies. Information from this study will hopefully provide enough information to determine a link between race, the advent of high risk pregnancies and cardiovascular markers. With this information it might be possible to intervene with approved pharmacological treatments.

Conditions

Timeline

Start date
2007-06-01
Primary completion
2008-12-01
Completion
2009-09-01
First posted
2008-04-07
Last updated
2012-04-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00653809. Inclusion in this directory is not an endorsement.

Racial Differences: Nitric Oxide(NO) and Endothelin-1(ET-1) in Preeclampsia (PreE) (NCT00653809) · Clinical Trials Directory